This $773,241 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under CFDA Program 93.279 (Drug Use and Addiction Research Programs) aims to develop an "Improving Health and Housing Outcomes through a Simulation and Economic Model (IHOUSE Model)." The key products and services to be delivered include: Employing a group model building approach to engage community stakeholders and inform the development of agent-based models simulating health outcomes and...
This $4,920,000 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support a randomized controlled trial to investigate the feasibility, acceptability, and preliminary effectiveness of using long-acting injectable naltrexone as a preventive measure for opioid overdose in individuals using stimulants and living with or at risk of HIV. The key objectives are to: 1) assess the use of naltrexone for...
This Project Grant award for $3,096,164 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a study to evaluate the efficacy and implementation of a peer-led Motivational Interviewing intervention called MI-CHANCE. The intervention aims to promote uptake of drug checking services and safer drug use behaviors to reduce overdose incidence among people who use drugs in San Diego County. The 5-year study, starting in September...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,223,769.00 to the University of California, San Diego (UCSD) to conduct a comprehensive investigation into the intersection of HIV infection and opioid use on neuroinflammation and neurotoxicity. The 5-year project, running from April 2025 to January 2030, will analyze brain specimens from persons with and without HIV to determine the...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Federal Grant Program "Drug Use and Addiction Research Programs" (CFDA 93.279), provides $1,607,146 over 2 years to NDRI-USA Inc., a non-profit research organization based in New York. The funding will support the development of technology-based interventions to encourage drug checking, distribution of harm reduction supplies, and linkage to substance use services. The project aims to address the...
This $2,316,128 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to design and assess tailored harm reduction strategies to address the overdose crisis across six distinct jurisdictions. The project, titled "REVERSING OVERDOSE EPIDEMICS THROUGH SIMULATION, COLLABORATION, AND UNIFIED EFFORTS (RESCUE)," will collaborate with health departments and community partners to evaluate the effectiveness,...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $688,271 to Yale University to conduct an integrated study on spatial and temporal variability in a state's illicit drug market. The key products and services delivered through this 5-year award include: Expanding street-based testing of drug samples collected from a representative sample of people who use drugs in Connecticut using an...
This $184,613 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the training of a Chicana epidemiologist in intervention science and phylogenetic analysis. The goal is to address the co-occurring epidemics of HIV, hepatitis C (HCV), and opioid use among Latino persons who inject drugs (PWID) living along the Texas-Mexico border. The key products and services to be delivered through this award include:...
This Project Grant award of $388,857.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is funding a study on the direct and indirect effects of disasters on drug-related outcomes. The research aims to use quasi-experimental methods and federal disaster data to examine the impact of disasters on mortality, substance use, and related mechanisms like psychological distress and treatment disruption. The study also plans to...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $357,750 to the University of California, San Diego (UCSD) to conduct research on opioid self-administration and addiction in middle-aged rats. The study aims to investigate how the middle-age developmental stage may influence sensitivity to opioids like oxycodone, heroin, and fentanyl, and the propensity for opioid self-administration, compared to...